0       0


MN1-4: What's New with Reimbursement and Coding for Blood Products, Transfusion Medicine and Cellular Therapies?


Oct 21, 2019 8:30am ‐ Oct 21, 2019 10:00am

Description

"What's New with Reimbursement and Coding for Blood Products, Transfusion Medicine and Cellular Therapies?" will provide attendees with an update on billing requirements and reimbursement policies that impact blood products, transfusion medicine and cellular therapies. In addition, speakers will discuss AABB's activities related to coding and reimbursement. Session attendees will have the opportunity to have their coding and billing questions answered by the experts.

Learning Objectives:

  • Describe updates to relevant Medicare policies impacting reimbursement for blood and transfusion medicine.
  • Describe updates to payment policies for cellular therapies.
  • Describe recent advocacy initiatives aimed at ensuring appropriate Medicare reimbursement for blood, transfusion medicine and cellular therapies.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content